Active substance
Fenticonazole
- SFDA 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| DERMA - LOMEXIN (LOMEXIN) 2% SPRAY | 2 % | Nasal spray · Topical | 1 Spray Container | SAR 22.05 | NCE · Prescription | RECORDATI | Withdrawn by MAH · Not Marketed |
| DERMA-LOMEXIN (LOMEXIN) 2% CREAM | 2 % | Nasal cream · Nasal use | 1 Tube | SAR 15.35 | NCE · Prescription | RECORDATI | Withdrawn by MAH · Not Marketed |
| GYNO-LOMEXIN 2% vaginal cream | 2 % | Vaginal cream · Vaginal use | 1 Tube | SAR 24.95 | NCE · Prescription | RECORDATI | Withdrawn by MAH · Not Marketed |
| GYNO-LOMEXIN 200 mg vaginal capsule | 200 mg | Vaginal capsule · Vaginal use | 6 Blister | SAR 25.50 | NCE · Prescription | RECORDATI | Withdrawn by MAH · Not Marketed |
| GYNO-LOMEXIN 600 mg vaginal capsule | 600 mg | Vaginal capsule · Vaginal use | 1 Blister | SAR 17.00 | NCE · Prescription | RECORDATI | Withdrawn by MAH · Not Marketed |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.